AptarGroup Inc (ATR, Financial), a company specializing in the design and manufacturing of a broad range of drug delivery, consumer product dispensing, and active material science solutions, recently saw a significant insider transaction. Marc Prieur, the Segment President, sold 3,200 shares of the company on May 7, 2024. The transaction was filed with the SEC and can be viewed in detail here.
The shares were sold at a price of $148.92, valuing the transaction at approximately $476,544. This sale is part of a broader trend observed over the past year, where the insider has sold a total of 14,400 shares. Notably, there have been no purchases by the insider during this period.
Examining the broader insider activity for AptarGroup Inc, there have been no insider buys in the past year, contrasted with 14 insider sells. This pattern of transactions provides insights into insider sentiment at the company.
Regarding the company's valuation, AptarGroup Inc currently holds a market cap of approximately $9.92 billion. The stock's price-earnings ratio stands at 32.13, which is above both the industry median and the company's historical median.
The GF Value, an intrinsic value estimate from GuruFocus, is set at $130.41 for AptarGroup Inc, suggesting that the stock is modestly overvalued with a price-to-GF-Value ratio of 1.14.
This valuation is based on historical trading multiples, an adjustment factor from GuruFocus for past performance, and future business performance estimates from analysts.
The recent insider selling activity, coupled with the stock's valuation metrics, provides important data points for investors monitoring AptarGroup Inc's stock performance and insider behaviors.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
